Updated NCE Content Outline
For NCE exams administered ON or AFTER 1/2/2024
SEE content areas are uniform at 25% each

I. Basic Sciences (20%)

A. Anatomy and physiology

  1. Cardiovascular
  2. Respiratory
  3. Central nervous system
  4. Musculoskeletal
  5. Endocrine
  6. Hepatic and renal
  7. Hematologic
  8. Gastrointestinal
  9. Immune
    B. Pathophysiology
  10. Cardiovascular
    a. Ischemic heart disease
    b. Valvular heart disease
    c. Congenital heart defects
    d. Cardiac conduction and rhythm abnormalities
    e. Cardiovascular and peripheral vascular abnormalities
    f. Infectious diseases
    g. Pericardial diseases
    h. Cardiomyopathy and heart failure
  11. Respiratory
    a. Obstructive diseases
    b. Restrictive diseases
    c. Infectious diseases
    d. Pulmonary vascular abnormalities
    e. Altered airway anatomy
  12. Central nervous system
    1
    a. Neurodegenerative diseases
    b. Myelin diseases
    c. Cerebrovascular diseases
    d. Neuropathies
    e. Psychiatric disorders
    f. Spinal cord disorders
    g. Intracranial tumor
    h. Congenital abnormalities (e.g., cerebral palsy)
    i. Seizure disorders
    j. Intracranial hypertension
    k. Thermoregulation
  13. Musculoskeletal
    a. Myopathies/metabolic abnormalities (e.g., malignant hyperthermia)
    b. Neuromuscular diseases
    c. Skeletal diseases
    d. Musculoskeletal disorders (genetic and acquired)
  14. Endocrine
    a. Thyroid and parathyroid disorders
    b. Pituitary disorders
    c. Adrenal disorders
    d. Pancreatic disorders (endocrine disorders)
    e. Other endocrine disorders (thymus-, hypothalamus-, androgen-
    ,
    and metabolic-related disorders)
  15. Hepatic
    a. Infectious diseases
    b. Biliary tract and bilirubin disorders
    c. Cirrhotic disorders
    d. Hepatovascular abnormalities
  16. Renal
    a. Intrinsic kidney disorders
    b. Acute kidney injury
    c. Chronic kidney disease
  17. Hematologic
    a. Anemias
    b. Hemoglobin disorders
    c. Coagulation disorders
  18. Gastrointestinal
    a. Esophageal disorders
    b. Gastric disorders
    c. Pancreatic disorders (exocrine disorders)
    d. Intestinal disorders
    e. Tumors/secreting lesions
    f. Malabsorption disorders
    2
  19. Immune
    a. Infectious disorders (e.g., HIV, AIDS)
    b. Hypersensitivity disorders (Type I-IV)
    c. Autoimmune diseases
  20. Other conditions
    a. Cancer
    b. Burns (inhalational, cutaneous)
    c. Trauma
    d. Substance use disorder (alcohol, nicotine, other)
    e. Sepsis
    C. Pharmacology
  21. General principles
    a. Pharmacodynamics
    b. Pharmacokinetics
    c. Pharmacology-related mathematics
  22. Inhalation anesthetics
  23. Intravenous anesthetics and antagonists
    a. Barbiturates
    b. Sedative/hypnotics (e.g., propofol, etomidate, ketamine,
    dexmedetomidine)
    c. Benzodiazepines and benzodiazepine antagonists
    d. Opioid agonists, agonist-antagonists, and antagonists
  24. Depolarizing and nondepolarizing neuromuscular relaxants and antagonists
  25. Local anesthetics
  26. Lipid emulsion
  27. Regional anesthesia adjuncts (neuraxial and peripheral)
  28. Anticholinergics/cholinergic agonists
  29. Non-opioid analgesics
  30. Cardiovascular medications
    a. Inotropes
    b. Phosphodiesterase inhibitors
    c. Cardiac glycosides (e.g., digitalis)
    d. Alpha- and beta-receptor agonists and antagonists
    e. Centrally acting alpha2-adrenergic agonists
    f. ACE inhibitors
    g. Angiotensin II receptor inhibitors
    h. Vasodilators
    i. Nitric oxide
    j. Antidysrhythmics
    k. Calcium channel blockers
  31. Bronchodilators
    3
  32. Psychopharmacologic therapy
    a. Antidepressants
    b. Antipsychotics
    c. Antiparkinsonian drugs
    d. Others
  33. Prostaglandins
  34. Histamine receptor antagonists
  35. Antiemetics
    a. 5-HT3 receptor antagonists
    b. Gastrointestinal prokinetic medications (metoclopramide)
    c. Antacids
    d. Other
  36. Insulin
  37. Hypoglycemics
  38. Diuretics
  39. Anticoagulants and antagonists
    a. Heparin and low-molecular-weight heparins
    b. Heparin reversal—protamine
    c. Antiplatelet medications
    d. Oral anticoagulants
    e. Oral anticoagulant reversal
    f. Thrombolytics
    g. Thrombin inhibitors
  40. Procoagulants (e.g., antifibrinolytics, DDAVP)
  41. Antimicrobials and antivirals
  42. Antiepileptics
  43. Lipid-lowering agents
  44. Herbal remedies and dietary supplements
  45. Minerals and electrolytes
  46. Dantrolene
  47. Steroids (e.g., dexamethasone, hydrocortisone)
  48. Tocolytics
  49. Uterotonics
  50. Intravenous dyes
  51. Cannabinoids
    D. Applied chemistry, biochemistry, physics, and mathematics
  52. Chemistry and biochemistry
    a. Aqueous solutions and concentrations
    b. Acids, bases, and salts
    c. Chemical reactions: oxidation, reduction, hydrolysis, and conjugation
    d. Metabolism
    4
    II. e. Cellular mechanisms of action
    f. Drug receptor interaction
  53. Physics
    a. Units of measurement
    b. Gases and gas laws
    c. Solubility, diffusion, and osmosis
    d. Pressure and fluid flow
    e. Electricity and electrical safety
    f. Vaporization and humidification
    g. Measurement of oxygen, carbon dioxide, and hydrogen ions
  54. Nonpharmacology-related mathematics

  55. Equipment, Instrumentation and Technology (20%)
    A. Anesthetic delivery systems
  56. High/low pressure gas sources
  57. Regulators/manifolds
  58. Flowmeters, valves, floats
  59. Vaporizers
  60. Proportioning systems
  61. Pressure failure safety devices
  62. Failsafe devices
  63. Ventilator
  64. Carbon dioxide absorbents
  65. Anesthetic circuits
    a. Rebreathing, circle system
    b. Nonrebreathing
    c. Modified nonrebreathing
  66. Pneumatic and electronic alarm devices
    B. Airway equipment
  67. Face masks
  68. Laryngoscope
    a. Rigid
    b. Video laryngoscope
    c. Optically enhanced scopes
  69. Flexible fiberoptic bronchoscope
  70. Endotracheal tube
  71. Endobronchial tube
    a. Double-lumen tubes
    5
    b. Bronchial blockers
  72. Airways
    a. Oral
    b. Nasal
  73. Tracheostomy tubes
  74. Supraglottic airways (e.g., LMA)
  75. Intubating supraglottic airways
  76. Jet ventilation
  77. Intubating stylets
  78. Cricothyrotomy (needle and surgical)
  79. Intubation aids (e.g., bougie, exchange catheter)
    C. Monitoring devices
  80. Central nervous system
    a. Evoked potential
    b. Intracranial pressure
    c. Modified EEG monitor
    d. Cerebral oximetry
  81. Cardiovascular
    a. Electrocardiogram (3-lead and 5-lead)
    b. Arterial pressure monitoring
    c. Noninvasive blood pressure monitoring
    d. Central venous pressure monitoring
    e. Pulmonary artery pressure monitoring/SvO2
    f. Hemodynamic monitoring
    g. Precordial/esophageal stethoscope
    h. Transesophageal echocardiogram
  82. Respiratory
    a. Capnography
    b. Airway gas analysis
    c. Pulse oximetry
    d. Airway pressure
    e. Blood gas analysis
  83. Others
    a. Peripheral nerve stimulator (qualitative and quantitative)
    b. Temperature monitoring
    c. Maternal/fetal monitoring
    D. Patient warming equipment
  84. Fluid/blood warmers
  85. Forced air warming devices
  86. Heat and moisture exchanger (HME)
    6
  87. Radiant warmers
    E. Infusion devices (e.g., rapid infusers)
    F. Imaging and imaging safety
  88. Ultrasound
  89. Fluoroscopy
  90. Radiography
    III. General Principles of Anesthesia (35%)
    A. Ethical considerations
  91. Autonomy, beneficence, nonmalfeasance
  92. Research ethics
    B. Legal issues
  93. Advance healthcare directives
  94. Informed consent
  95. Disclosure of errors/ injuries
  96. Legal doctrines
  97. Torts
  98. Scope of practice
  99. Standards of practice
  100. Billing
    C. Safety and wellness
  101. Provider substance abuse disorder
  102. Issues surrounding patient safety
  103. Impaired provider
  104. Wellness initiatives and peer assistance
    D. Preoperative assessment and preparation of patient
    E. Fluid volume assessment and management
  105. 2. 3. Fluid/blood component therapy replacement (including plasma expanders)
    Bloodless medicine (including blood salvage devices and hemodilution
    techniques)
    Goal-directed fluid management (crossover with equipment)
    7
  106. Massive transfusion protocol
  107. Thromboelastography
    F. Positioning
  108. Techniques
  109. Physiologic alterations
  110. Complications
    G. Utilization and interpretation of testing data
  111. 2. Lab tests (blood gases, activated clotting time)
    Diagnostic exams (including basic 12-lead ECG interpretation)
    H. Airway management
  112. Assessment
  113. Techniques, procedures, and devices
  114. Complications
  115. Difficult airway management (difficult airway algorithm)
    I. Local/regional anesthetics (technique, physiologic alterations, complications)
  116. Anatomy
  117. Infiltration
  118. Topical
  119. Neuraxial blocks
  120. Peripheral blocks
  121. Other blocks (airway, retrobulbar)
  122. Ultrasound and/or nerve stimulator guided concepts and techniques
  123. Management of complications (e.g., local anesthetic systemic toxicity)
    J. Light, moderate, and deep sedation (monitored anesthesia care)
    K. Total intravenous anesthesia
    L. Pain
  124. Pain theory (anatomy, physiology, pathology, and psychodynamics)
    a. Acute
    b. Chronic
  125. Pain management
    a. Acute
    b. Chronic
    8
    c. Multimodal pain therapy
    M. Enhanced recovery after surgery (ERAS)
    N. Hypotensive technique and risks
    O. Postanesthesia care/respiratory therapy
    P. Infection control
  126. 2. Provider (e.g., personal protective equipment, room air handling,
    ultraviolet sanitizers)
    Patient (e.g., aseptic technique, workstation cleanliness, needle safety)
    Q. Intraoperative fire safety
    IV. Anesthesia for Surgical Procedures and Special Populations (25%)
    A. Surgical and diagnostic anesthesia, including management of complications
  127. Intra-abdominal
    a. Hepatobiliary system
    b. Gastrointestinal tract procedures
    c. Endocrine organ procedures
    d. Renal/genitourinary
    e. Gynecologic procedures
    f. Peritoneal procedures (including hernia repair)
  128. Extrathoracic
    a. Breast
    b. Plastics and/or reconstructive
  129. Head
    a. Extracranial
    i. Otolaryngological
    ii. Ophthalmologic
    iii. Nasal
    iv. Craniofacial
    v. Plastics and/or reconstructive
    vi. Orthodontic/dental
    b. Intracranial
    i. Decompression (burr holes, ventriculoperitoneal shunt)
    ii. Space-occupying lesion
    9
    iii. Vascular
    iv. Transsphenoidal hypophysectomy
    v. Stereotactic procedures
  130. Cardiac anesthesia
    a. Open procedures (e.g., coronary artery bypass grafting)
    b. Minimally invasive procedures (e.g., transcatheter aortic valve
    replacement/implantation [TAVR/TAVI], left atrial appendage closure
    implant, mitral clips)
    c. Interventional cardiology (e.g., pacemakers, automated internal
    cardiac defibrillator devices, electrophysiology cases)
    d. Management of patients with cardiac devices (e.g., ventricular assist
    device, extracorporeal membrane oxygenation, intraarterial balloon
    pump)
  131. Noncardiac intrathoracic (including open and thoracoscopic approach)
    a. Diaphragm
    b. Endoscopic procedures (bronchoscopy, mediastinoscopy)
    c. Esophagus
    d. Lung
    e. Mediastinum
  132. Neck
    a. Larynx/trachea
    b. Lymph node biopsies
    c. Parathyroid/thyroid
    d. Neck tumors
  133. Neuroskeletal
    a. Cervical spine (anterior and posterior approach)
    b. Laminectomy/discectomy fusions at all levels
    c. Pain management procedures
    d. Other
  134. Orthopedic
    a. Arthroscopic procedures
    b. Closed reduction
    c. Fractures
    d. Total joint replacements/arthroplasty
    e. Procedures of the hand and foot
  135. Perineal and pelvic procedures
    a. Gynecologic
    b. Genitourinary
    c. Anal/rectal
  136. Vascular (open versus endovascular)
    a. Carotid
    b. Thoracic
    c. Abdominal (including renal)
    10
    d. Extremity
    i. Occlusive disease
    ii. Vascular access
    e. Thromboembolic prevention
    f. Surgical management of portal hypertension
  137. Non-operating-room anesthesia (NORA)
    a. Diagnostic imaging and radiology
    b. Electroconvulsive therapy
    c. Interventional radiology
    d. Radiation therapy
    e. Endoscopy
  138. Robotic/laparoscopic surgery
  139. Other surgical procedures
    a. Trauma
    b. Burns
    c. Organ transplants (including management of posttransplant
    patient for nontransplant surgery)
    d. Organ procurement
    e. Laser procedures
    B. Anesthesia for special populations
  140. Pediatrics
    a. Anatomy, physiology, and pathophysiology
    i. Normal
    ii. Prematurity
    iii. Congenital abnormalities
    b. Pharmacology
    c. Anesthesia techniques/procedures
    d. Management of complications
  141. Obstetrics
    a. Anatomy, physiology, and pathophysiology
    b. Pharmacology
    c. Anesthesia techniques/procedures
    d. High-risk parturients
    e Nonobstetric surgery in the parturient
    f. Management of complications (e.g., amniotic fluid embolism, HELLP
    syndrome)
    g. Postpartum hemorrhage
  142. Geriatrics
    a. Anatomy, physiology, and pathophysiology
    b. Pharmacology
    c. Anesthesia techniques/procedures
    11
    d. Management of complications (e.g., postoperative cognitive dysfunction)
  143. Obesity
    a. Anatomy, physiology, and pathophysiology
    b. Pharmacology
    c. Anesthesia techniques/procedures (including bariatric)
    d. Management of complications
  144. Substance use disorder population
    a. Medication-assisted therapy (MAT) (e.g., methadone, buprenorphine)
    b. Pharmacologic interactions (e.g., acute intoxication)
    c. Pain management
    d. Management of complications
  145. Immune compromised and oncology patients
    a. Pharmacology
    b. Anesthesia techniques/procedures
    c. Management
    12